Despite a new EU-U.S. trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a U.S. national security investigation that could later impose duties of up to 15%.
Breakdown
- Pharmaceutical tariffs remain at 0% despite the new EU-US trade deal.
- Most EU goods imported to the US will now face a 15% tariff. 44s
- The US is reviewing pharmaceutical imports for national security concerns. 52s
- Any changes to pharma tariffs will be announced after the US review is complete. 1m 0s
- The European Commission expects a 15% cap on pharma tariffs, but the future remains undecided. 1m 4s
See The Full Story

Global Tariffs
Donald Trump has signed an order to impose tariffs imports into the U.S. from countries including China, Mexico and Canada.